Health Care Resource Utilization and Economic Burden Associated With Congenital Cytomegalovirus Infection: A Longitudinal Analysis of Data From Clinical Practice at a Large Health Care Provider in Israel
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 44 (2) , 282-294
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp and Dohme United Kingdom
- National Institutes of Health
- Merck
This publication has 16 references indexed in Scilit:
- Economic cost of congenital CMV in the UKArchives of Disease in Childhood, 2018
- Healthcare costs attributable to congenital cytomegalovirus infectionArchives of Disease in Childhood, 2018
- Congenital CytomegalovirusThe Pediatric Infectious Disease Journal, 2017
- Health care use2017
- Purchasing power parities (PPP)2017
- Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic reviewReviews in Medical Virology, 2017
- Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus InfectionJAMA Pediatrics, 2016
- Hearing Loss and Congenital CMV Infection: A Systematic ReviewPediatrics, 2014
- Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countriesInternational Journal of Infectious Diseases, 2014
- Neuropathogenesis of Congenital Cytomegalovirus Infection: Disease Mechanisms and Prospects for InterventionClinical Microbiology Reviews, 2009